Search

everythinglearnresearchcommunity

for

Search:↓

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Finasteride users have higher odds of certain health issues and lower odds of specific lifestyle factors compared to nonusers.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Using A132 hair dye with sunlight can cause skin damage and hair loss.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

Some people using minoxidil for hair loss developed an allergic skin reaction, often related to an ingredient that helps minoxidil work better.

The new compound may be a safer alternative to finasteride for prostate protection.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

A synthetic sandalwood odorant can boost antimicrobial production in hair follicles, making them more resistant to bacteria.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Shampoo B, which uses water-soluble silicone, is better at detangling hair in wet conditions due to its two-layer conditioning film.

The inhibitor DPP can promote hair growth.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Four new substances—minoxidil, ferrimanitol ovalbumin, clarithromycin, and glucosamine-hydrochloride—can cause occupational asthma.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Flutamide, dutasteride, and finasteride dissolve differently in supercritical carbon dioxide, with dutasteride dissolving the least.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Finasteride helps female-pattern hair loss.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Metabolic syndrome reduces effectiveness of hair loss treatment.